Equities

Hyperfine Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HYPR:NMQ

Hyperfine Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.11
  • Today's Change0.02 / 1.83%
  • Shares traded359.94k
  • 1 Year change-7.50%
  • Beta1.0840
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.

  • Revenue in USD (TTM)10.59m
  • Net income in USD-40.05m
  • Incorporated2021
  • Employees111.00
  • Location
    Hyperfine Inc351 New Whitfield StreetGUILFORD 06437United StatesUSA
  • Fax+1 (302) 636-5454
  • Websitehttps://hyperfinemri.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
InspireMD Inc7.78m-46.20m74.15m85.00--1.14--9.53-0.8396-0.83960.1391.530.12071.934.4691,517.65-71.65-60.63-83.34-71.7724.9120.76-593.89-377.986.17--0.00--12.9613.50-60.70--37.62--
MaxCyte Inc34.42m-45.63m76.76m114.00--0.4257--2.23-0.4298-0.42980.32431.690.1490.76575.35301,921.10-19.75-13.01-21.30-14.0179.9787.32-132.58-72.437.27--0.00---6.4412.31-8.26--5.37--
DarioHealth Corp24.73m-37.11m79.21m196.00--1.06--3.20-12.47-12.478.2911.070.21732.226.51126,183.70-37.17-63.89-42.41-75.3056.8634.31-171.09-262.344.02-69.690.2901--32.8629.0435.47--7.09--
Xtant Medical Holdings Inc133.08m1.75m81.83m217.0057.191.6212.240.61490.01020.01020.91580.35991.301.225.78613,285.701.71-11.382.57-16.1762.0259.371.32-9.641.061.570.3635--28.4412.64-2,592.27--36.16--
Vivani Medical Inc0.00-26.03m95.82m42.00--55.45-----0.4417-0.44170.000.02130.00----0.00-76.61-43.12-94.91-49.69------------0.00------8.44--2.43--
Neuronetics Inc129.87m-44.50m97.25m716.00--3.55--0.7488-0.8344-0.83442.240.39971.1813.877.31181,386.90-40.63-29.61-52.56-36.9650.4374.98-34.35-53.712.09-4.310.6768--4.963.63-44.78--12.51--
Alpha Teknova Inc39.80m-18.22m107.06m173.00--1.47--2.69-0.3409-0.34090.74461.360.34353.778.17230,063.60-15.73-19.57-16.94-20.9730.9738.24-45.78-63.704.27-28.650.1525--2.8912.6827.28---16.96--
Hyperfine Inc10.59m-40.05m111.70m111.00--3.32--10.55-0.5243-0.52430.13850.33390.1910.88591.8195,414.41-72.23-45.05-88.25-48.8646.1230.47-378.17-757.553.06--0.00--16.84--7.95--9.44--
Picard Medical Inc4.77m-33.80m114.97m75.00--14.43--24.08-0.4673-0.46730.0660.1081------63,653.33---------10.03---660.85--0.9373-0.78080.0134---12.93---31.86------
Treace Medical Concepts Inc218.88m-50.11m118.52m477.00--1.33--0.5415-0.7947-0.79473.481.401.071.047.66458,865.80-24.47-24.03-30.34-29.1779.8780.99-22.89-24.972.36-22.690.3829--11.8939.65-12.55--57.11--
Pro-Dex Inc70.23m11.19m126.57m181.0011.783.1010.171.803.353.3521.0312.731.182.654.40388,016.6018.8712.0623.8815.2428.0929.8115.9411.732.14--0.24180.0023.6813.84322.107.9919.14--
CVRx Inc55.97m-52.02m130.24m206.00--2.70--2.33-2.02-2.022.181.830.46840.74586.49271,694.20-43.53-37.08-47.98-40.0284.4981.33-92.95-151.188.60-8.490.5072--30.5352.31-45.55--66.61--
LifeMD Inc252.34m-7.71m133.82m304.00--98.5427.100.5303-0.1711-0.17115.660.02823.6410.8333.00830,075.60-4.29-109.71-31.14-396.0386.9685.59-1.18-33.120.66450.31640.00--39.2776.327.23------
Fonar Corp105.43m6.99m136.36m535.0017.810.69499.721.291.041.0415.7426.690.489722.331.28197,073.504.346.774.427.1941.0745.468.8613.748.46--0.0021--1.434.02-21.260.1719-12.96--
LENSAR Inc59.14m-51.52m146.08m140.00------2.47-4.39-4.394.99-1.020.89461.7911.51422,435.70-77.94-32.69-121.49-38.9546.1551.51-87.12-54.770.6671------26.8711.87-118.34---40.48--
Anika Therapeutics Inc82.20m13.91m147.24m288.0010.841.007.281.790.9419-2.285.7010.180.39070.4863.25285,430.606.61-1.877.39-2.0654.2960.7416.92-4.734.47--0.00---0.73270.9077-156.70--24.14--
Data as of Feb 13 2026. Currency figures normalised to Hyperfine Inc's reporting currency: US Dollar USD

Institutional shareholders

9.15%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 20253.16m3.85%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 20251.12m1.36%
Catalio Capital Management LP (Investment Management)as of 30 Sep 2025684.54k0.83%
Geode Capital Management LLCas of 30 Sep 2025672.01k0.82%
BlackRock Fund Advisorsas of 30 Sep 2025575.67k0.70%
Vanguard Fiduciary Trust Co.as of 31 Dec 2025384.25k0.47%
Isthmus Partners LLCas of 31 Dec 2025313.35k0.38%
SSgA Funds Management, Inc.as of 30 Sep 2025250.00k0.30%
Journey Strategic Wealth LLCas of 30 Sep 2025186.74k0.23%
Newton Investment Management North America LLCas of 30 Sep 2025166.29k0.20%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.